Search Results - "Levine, Jedd"
-
1
Btm-3566, a Novel Activator of the Mitochondrial Stress Response Promotes Robust Therapeutic Responses in Vitro and In Vivo in Diffuse Large B-Cell Lymphoma
Published in Blood (23-11-2021)“…Relapsed/refractory diffuse large B-cell lymphomas (r/r-DLBCL) are a therapeutic challenge, especially in patients not suitable for high dose chemotherapy,…”
Get full text
Journal Article -
2
Development and validation of blood-based predictive biomarkers for response to PD-(L)-1 checkpoint inhibitors: Evidence of a universal systemic core of 3D immunogenetic profiling across multiple oncological indications
Published in Journal of clinical oncology (01-06-2022)“…e14525 Background: Unprecedented advantages in cancer treatments with immune checkpoint inhibitors (ICI) remain limited to a subset of patients, with high…”
Get full text
Journal Article -
3
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1
Published in Molecular cancer therapeutics (01-11-2023)“…DLBCL are aggressive, rapidly proliferating tumors that critically depend on the ATF4-mediated integrated stress response (ISR) to adapt to stress caused by…”
Get full text
Journal Article -
4
Abstract 45: BTM-3528 potently induces G1/G0 cell cycle arrest and is efficacious in preclinical models of diffuse large B-cell lymphoma
Published in Clinical cancer research (15-12-2017)“…Abstract Aberrant regulation of cell cycle control, integration of signals from oncogenic signaling pathways, and cancer cell metabolism play a key role in the…”
Get full text
Journal Article -
5
Economic impact and outcome benefits of integrating quantitative proteomics analysis to guide treatment strategies for metastatic breast cancer patients
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
6
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications
Published in Cancers (10-05-2023)“…Unprecedented advantages in cancer treatment with immune checkpoint inhibitors (ICIs) remain limited to only a subset of patients. Systemic analyses of the…”
Get full text
Journal Article -
7
Chemotherapy of malignant thymoma. Case report and review of the literature
Published in Cancer (15-03-1986)“…The authors report the case of a patient with malignant thymoma unresponsive to combination chemotherapy (cyclophosphamide, doxorubicin, vincristine, and…”
Get more information
Journal Article -
8
1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents
Published in Bioorganic & medicinal chemistry letters (15-09-2017)“…[Display omitted] A class of substituted 1-thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives was found to have potent anti-proliferative…”
Get full text
Journal Article -
9
Abstract PO-47: BTM-3566 induces complete tumor regression in diffuse large B-cell lymphoma: Regulation by the eIF2α kinase “heme-regulated inhibitor” and the mitochondrial protein FAM210B
Published in Blood cancer discovery (01-11-2020)“…Abstract BTM-3566 is a novel small-molecule compound with broad anticancer activity in hematologic and solid cancers, with exceptional activity against diffuse…”
Get full text
Journal Article -
10
Abstract A07: BTM 3566, a novel activator of the mitochondrial stress response promotes robust therapeutic responses in vitro and in vivo in diffuse large B-cell lymphoma
Published in Blood cancer discovery (06-09-2022)“…Abstract Relapsed/refractory diffuse large B-cell lymphomas (r/r-DLBCL) are a therapeutic challenge as they are highly heterogeneous both clinically and…”
Get full text
Journal Article -
11
Abstract 3784: BTM-3655 co-opts mitochondrial quality control pathways to induce apoptosis, and complete tumor regression in DLBCL cell lines, xenografts and PDX models
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Cellular integrated stress response (ISR) pathways are induced by multiple triggers - viral RNA, nutrient deprivation, protein misfolding and…”
Get full text
Journal Article -
12
-
13
Clinical and Immunologic Effects of Recombinant Leukocyte A Interferon in Eight Patients With Advanced Cancer
Published in JAMA : the journal of the American Medical Association (26-03-1982)“…The clinical and immunologic effects of a biosynthetic human leukocyte interferon, recombinant leukocyte A interferon (IFL-rA), are reported in eight patients…”
Get full text
Journal Article -
14
3T3-L1 adipocytes promote the growth of mammary epithelium
Published in Experimental cell research (01-03-1984)“…Murine mammary epithelium grows in association with predominantly adipocyte stroma in vivo. To investigate potential growth-promoting effects of adipocytes on…”
Get more information
Journal Article -
15
Cell-Cell Interactions Promote Mammary Epithelial Cell Differentiation
Published in The Journal of cell biology (01-05-1985)“…Mammary epithelium differentiates in a stromal milieu of adipocytes and fibroblasts. To investigate cell-cell interactions that may influence mammary…”
Get full text
Journal Article -
16
The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer
Published in Cancer (15-01-1984)“…The dose of adjuvant chemotherapy for breast cancer may be an important factor in the success of the treatment program. In a retrospective analysis, the…”
Get more information
Journal Article